Ian Christopher Lim
Nurse Practitioner • Hammonton, NJ
33 Mardor Ave
Hammonton, NJ 080371968
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 19, 2021; this date does not establish years in practice.
-
Published CMS data list 2,741 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Famotidine — 1,028 prescription fills, including refills.
- Pantoprazole Sodium — 798 prescription fills, including refills.
- Omeprazole — 323 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in New Jersey (2024, 875 clinicians with data). Median for this group: 308. Middle half: 81 to 1,016.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 235 in 2023 to 2,741 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023–2024.
Practice Location & Contact Primary Location
33 Mardor Ave
Hammonton, NJ 080371968
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
7,250 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$102,513 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $563.86 across 28 records.
By nature of payment
- Food and Beverage: $563.86 across 28 records.
Reporting-company totals (3 largest of 14)
- Ipsen Biopharmaceuticals, Inc: $100.01 across 4 records.
- Takeda Pharmaceuticals U.S.A., Inc.: $98.12 across 5 records.
- Salix Pharmaceuticals, a division of Bausch Health US, LLC: $71.13 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2021
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Hammonton and New Jersey
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in New Jersey (2024, 875 clinicians with data). Median for this group: 308. Middle half: 81 to 1,016.
Too few clinicians listed under Nurse Practitioner in Hammonton have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Nurse Practitioner in New Jersey (2024, 875 clinicians with data). Median for this group: $22,535. Middle half: $1,330 to $113,516.
Too few clinicians listed under Nurse Practitioner in Hammonton have Medicare Part D data for 2024 to compare.
5 active clinicians are listed under Nurse Practitioner with a practice address in Hammonton, NJ (1,964 in New Jersey).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1066% from 235 in 2023 to 2,741 in 2024.
- 2023: 235
- 2024: 2,741
-
30-day fills
30-day fills increased 987% from 667 in 2023 to 7,250 in 2024.
- 2023: 667
- 2024: 7,250
-
Part D drug cost
Part D drug cost increased 1305% from $7,298 in 2023 to $102,513 in 2024.
- 2023: $7,298
- 2024: $102,513
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $75.32 in 2023 to $563.86 in 2025.
- 2023: $75.32
- 2024: $399.88
- 2025: $563.86
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 28 records totaling $563.86.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $33.80 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
IQIRVO | General | $27.93 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $27.27 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
IQIRVO | General | $26.06 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
IQIRVO | General | $25.12 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $25.10 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $24.20 |
| QOL Medical, LLC |
Food and Beverage
In-kind items and services
|
Sucraid | General | $24.09 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $23.86 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $21.79 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
IQIRVO | General | $20.90 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $20.70 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $19.91 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $19.65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $18.74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $18.59 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
OMVOH | General | $18.04 |
| Celltrion USA Inc. |
Food and Beverage
In-kind items and services
|
VEGZELMA | General | $16.95 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $16.76 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $16.28 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
MAVYRET | General | $16.06 |
| Celltrion USA Inc. |
Food and Beverage
In-kind items and services
|
VEGZELMA | General | $15.20 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $15.09 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $14.96 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $14.91 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Famotidine | Famotidine | 1,028 | 86,108 | $15,480.39 | 426 |
| Pantoprazole Sodium | Pantoprazole Sodium | 798 | 65,140 | $10,788.59 | 321 |
| Omeprazole | Omeprazole | 323 | 25,594 | $4,281.66 | 138 |
| Sucralfate | Sucralfate | 90 | 7,243 | $6,305.54 | 52 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 79 | 6,995 | $4,398.77 | 34 |
| Dicyclomine Hcl | Dicyclomine Hcl | 78 | 6,444 | $2,340.60 | 48 |
| Metronidazole | Metronidazole | 57 | 652 | $324.15 | 57 |
| Lansoprazole | Lansoprazole | 49 | 4,272 | $2,679.44 | 24 |
| Linzess | Linaclotide | 35 | 1,890 | $32,101.94 | 13 |
| Ondansetron Odt | Ondansetron | 33 | 454 | $546.18 | 15 |
| Colestipol Hcl | Colestipol Hcl | 30 | 2,110 | $3,223.41 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 440 | $305.06 | 15 |
| Mirtazapine | Mirtazapine | 16 | 1,320 | $169.08 | — |
| Mesalamine | Mesalamine | 15 | 1,140 | $15,068.64 | — |
| Clenpiq | Sod Picosulf/Mag Ox/Citric Ac | 15 | 28 | $2,547.04 | 15 |
| Loperamide | Loperamide Hcl | 13 | 1,085 | $479.29 | — |
| Lactulose | Lactulose | 13 | 942 | $867.30 | — |
| Fluconazole | Fluconazole | 12 | 239 | $164.00 | — |
| Baclofen | Baclofen | 11 | 990 | $235.89 | — |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | 990 | $78.98 | — |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | 180 | $126.59 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-11-23NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
NUCC Taxonomy Code: 163WG0000X
Career & Practice History
NPI enumerated April 19, 2021.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from May 2021 to August 2026.
NPI Administrative Meta
Other Nurse Practitioners in Hammonton
Healthcare providers in HammontonMailing Address
33 Mardor Ave
Hammonton, NJ 080371968
Phone: 6094815915